{"id":"W1867789233","doi":"10.1200/jco.2012.30.15_suppl.lba1","title":"Primary results from EMILIA, a phase III study of trastuzumab emtansine (T-DM1) versus capecitabine (X) and lapatinib (L) in HER2-positive locally advanced or metastatic breast cancer (MBC) previously treated with trastuzumab (T) and a taxane.","year":2012,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"HER2/EGFR in Cancer Research","field":"Medicine","cited_by":83,"is_retracted":false,"has_abstract":true,"ca_institutions":"University of Toronto; Sunnybrook Health Science Centre","funders":"","keywords":"Lapatinib; Capecitabine; Medicine; Trastuzumab emtansine; Trastuzumab; Oncology; Internal medicine; Metastatic breast cancer; Breast cancer; Cancer; Gynecology; Colorectal cancer","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.003230915,0.0003568857,0.003100655,0.0002736147,0.00005007232,0.00001263376,0.0001836737,0.0002504909,0.000144671],"category_scores_gemma":[0.002429082,0.0002277648,0.0001348311,0.0004958261,0.0005594547,0.0002939738,0.00008639996,0.001384379,0.000001080625],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0008157017,"about_ca_system_score_gemma":0.003592645,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.002360991,"about_ca_topic_score_gemma":0.008142427,"domain_scores_codex":[0.9934989,0.001187377,0.003373923,0.0004886882,0.0008559586,0.0005951606],"domain_scores_gemma":[0.9908636,0.005309707,0.001909032,0.0003162237,0.0007603456,0.0008411157],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"observational","study_design_scores_codex":[0.5207486,0.02438756,0.05873552,0.0001823523,0.001893489,0.00296188,0.00600765,0.00003307585,0.000839036,0.00000131777,0.0002850506,0.3839245],"study_design_scores_gemma":[0.2984447,0.1514086,0.5389225,0.001458947,0.00185795,0.0009180638,0.005868028,0.0001496295,0.0001305721,0.000004965116,0.0005585541,0.0002775208],"study_design_candidate":"randomized_trial","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9942012,0.001966622,0.00004295833,0.001322362,0.0002302961,0.001703947,0.0002467417,0.00001057045,0.0002753004],"genre_scores_gemma":[0.9942498,0.002383856,0.002466797,0.0002652433,0.0004067536,0.00006128773,0.00002147724,0.00004842634,0.00009642373],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.4801869,"threshold_uncertainty_score":0.9287978,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.120029974007668,"score_gpt":0.4837508507159989,"score_spread":0.363720876708331,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}